Interpace Diagnostics Announces Participation at the DJCON18

Including Participation in the Panel on the Impact of AI and Bioinformatics in Healthcare PARSIPPANY, NJ, Oct. 24, 2018 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), announced today that the Company will present at the upcoming Dawson James 4th Annual Small Cap Growth Conference (“DJCON18”) being held on October 29th & …

Interpace Diagnostics Announces Participation at the DJCON18 Read More »